Wang HQ - Search Results

1

Pharmacokinetics of panaxatrol disuccinate sodium, a novel anti-cancer drug from Panax notoginseng, in healthy volunteers and patients with advanced solid tumors.

Yan Z, Zhu ZL, Wang HQ, Li W, Mi YX, Liu CX. Yan Z, et al. Among authors: wang hq. Acta Pharmacol Sin. 2010 Nov;31(11):1515-22. doi: 10.1038/aps.2010.114. Acta Pharmacol Sin. 2010. PMID: 21052087 Free PMC article. Clinical Trial.

2

[Treatment of advanced metastatic breast cancer with exemestane, a multicenter randomized controlled study of 195 cases].

Wang HQ, Ren CC, Feng WJ, Lin MB, Xiong YQ, Huang P, Zhao WH, Hao XS, Chen SB, Yan Z. Wang HQ, et al. Zhonghua Yi Xue Za Zhi. 2003 Feb 10;83(3):188-90. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12812657 Clinical Trial. Chinese.

3

[Treatment of malignant lymphoma by autologous hematopoietic stem cell transplantation combined with high dose radiotherapy and chemotherapy].

Wang HQ, Cui XZ, Ren XB, Liu XM, Dai RZ, Zhang HL, Huang WY, Li W, Hao XS. Wang HQ, et al. Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):948-51. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899794 Chinese.

4

[Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].

Cui XZ, Wang HQ, Liu XM, Zhang HL, Li W. Cui XZ, et al. Among authors: wang hq. Zhonghua Xue Ye Xue Za Zhi. 2007 Sep;28(9):609-11. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18246818 Chinese.

5

[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].

Liu XM, Wang HQ, Zhang HL, Qiu LH, Li W, Li LF, Cui XZ, Liu PF, Hao XS. Liu XM, et al. Among authors: wang hq. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):779-82. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173813 Clinical Trial. Chinese.

6

[Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].

Qiu LH, Wang HQ, Qian ZZ, Li W, Hou Y, Meng XR, Cui XZ, Hao XS. Qiu LH, et al. Among authors: wang hq. Zhonghua Wai Ke Za Zhi. 2010 May 15;48(10):743-6. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20646489 Chinese.

7

[Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].

Li LF, Wang HQ, Liu XM, Zhang HL, Qiu LH, Qian ZZ, Li W. Li LF, et al. Among authors: wang hq. Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):626-8. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22325226 Chinese.

8

[Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].

Hou Y, Wang HQ, Fu K, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Among authors: wang hq. Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):911-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340100 Chinese.

9

Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors.

Yan Z, Zhu ZL, Qian ZZ, Hu G, Wang HQ, Liu WH, Cheng G. Yan Z, et al. Among authors: wang hq. Acta Pharmacol Sin. 2012 Jun;33(6):852-8. doi: 10.1038/aps.2012.44. Acta Pharmacol Sin. 2012. PMID: 22669119 Free PMC article. Clinical Trial.

10

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

Hou Y, Wang HQ, Fu K, Liu XM, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Among authors: wang hq. Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):306-10. doi: 10.3760/cma.j.issn.0253-3766.2012.04.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22781046 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,331 results

Search Page

Filters